Joseph M. Feczko, Director at KERYX BIOPHARMACEUTICALS INC (KERX), bought 20,000 shares at $1.62 ($32K) on 2012-04-05, disclosed to the SEC on 2012-04-10.
Open-market purchase of $32k KERX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| KERX | BUY | 2011-03-22 | $87K | — | Filing → |
| PFE | SELL | 2007-04-25 | $561K | — | Filing → |
| PFE | SELL | 2007-02-15 | $1.8M | — | Filing → |